Monopar Therapeutics Inc.
Hedge Funds Holdings

Last updated:

Monopar Therapeutics Inc.‘s stocks are currently a part of 5 hedge funds’ portfolios, which represents 0.26% of the total amount of its stocks outstanding. This makes up a total of 33.00K shares of Monopar Therapeutics Inc.. Compared to the previous quarter, the number fell by -82.45% or -155.03K shares fewer. As for the holding position changes, 20% (1) of current hedge fund investors increased the number of shares held, 20% (1) of current holders sold a part of the shares held, and 40% (2) closed the holdings completely. 2 hedge funds are new holders of Monopar Therapeutics Inc. stock in Q1 2023, it is 40% of total holders.

Hedge funds holding Monopar Therapeutics (Q4 2019 – Q1 2023)

Number of hedge funds
Q4 2019 4
Q1 2020 4
Q2 2020 4
Q3 2020 4
Q4 2020 6
Q1 2021 12
Q2 2021 8
Q3 2021 8
Q4 2021 11
Q1 2022 11
Q2 2022 10
Q3 2022 8
Q4 2022 9
Q1 2023 5

Hedge funds changes in Monopar Therapeutics positions (Q4 2019 – Q1 2023)

Changes in positions
Q4 2019 40000
Q1 2020 3013-3
Q2 2020 2102-1
Q3 2020 11110
Q4 2020 21201
Q1 2021 62202
Q2 2021 0514-2
Q3 2021 03203
Q4 2021 31106
Q1 2022 12215
Q2 2022 01315
Q3 2022 12131
Q4 2022 3232-1
Q1 2023 2112-1

Top 50 hedge fund holders of Monopar Therapeutics Inc. (NASDAQ:MNPR)

Hedge fund Value Shares owned Portfolio share
VANGUARD GROUP INC 152K 99.87K 0.000%
GEODE CAPITAL MANAGEMENT, LLC 59K 39.17K 0.000%
NORTHERN TRUST CORP 55K 36.37K 0.000%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 16K 10.58K 0.000%
IFP ADVISORS, INC 13K 500 0.000%
UBS GROUP AG 8K 5.39K 0.000%
MORGAN STANLEY 6K 4K 0.000%
TOWER RESEARCH CAPITAL LLC (TRC) 5K 3.13K 0.000%
BLACKROCK INC. Larry Fink 0 0 0.000%
ROYAL BANK OF CANADA 0 0 0.000%